Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging

NAActive, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Esophageal Cancer
Interventions
OTHER

Injection of indocyanine green (ICG)dye

Patients will receive a perilesional injection of indocyanine green (ICG) before the laparoscopic phase of the esophagectomy.

DEVICE

Near-Infrared Image-Guided

Real-time near-infrared (NIR) fluorescence imaging will be performed by use of the Novadaq PINPOINT minimally invasive system with a laparoscopic camera.

PROCEDURE

Sentinel Lymph Node (SLN) mapping

Any identified SLNs will be dissected during the standard completion lymphadenectomy and esophagectomy.

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER